“Nothing to do with geopolitics”: WuXi Biologics CEO bullish in …
Jan 16, 2025 · A subsidiary of the Chinese contract development and manufacturing organization (CDMO), WuXi Vaccines, will sell its vaccine manufacturing facility in Dundalk, Ireland to …
Hong Kong-listed biologics company WuXi records € ... - The Irish Times
Jul 29, 2024 · The main Irish manufacturing arm of Hong Kong-listed biopharma group WuXi Biologics last year recorded “expected” operating losses of €72.6 million. In 2023, Wuxi …
WuXi ‘considering selling its Dundalk plant’: report - Independent.ie
Oct 4, 2024 · WuXi Biologics, which has a major manufacturing facility outside Dundalk, is considering selling some of its European production facilities, according to a report in the …
Merck Snaps Up WuXi Biologics Facility in Ireland for $500M
Jan 6, 2025 · Facing increasing global pressure, WuXi Biologics will sell its Ireland vaccines facility to Merck for $500 million. The two companies have been collaborating on the Dundalk …
How a €325m Irish factory became part of a ... - The Irish Times
Oct 18, 2024 · Wuxi Biologics Ireland now employs around 600 people on the sprawling Dubalk campus. Seen from today, the backing by Government, IDA and ISIF of the rapidly-growing …
Pharmaceutical Technology
Jan 7, 2025 · The Dundalk facility, which WuXi Biologics built in 2019 for $240m, became operational in 2021 and currently employs 200 staff. The site provides drug substance and …
MSD acquires WuXi's vaccine facility in Dundalk for €500m
Jan 6, 2025 · China's WuXi Biologics is to sell its vaccine manufacturing site in Dundalk to MSD Ireland in a €500m deal. The acquisition is expected to be completed in the first half of this …
WuXi Biologics to Sell Irish Vaccine Facility to Merck for $500 …
The Chinese contract drugmaker will sell its vaccine factory in Dundalk, Ireland, to U.S.-based Merck for about $500 million, it said in an exchange filing late Monday.
WuXi Biologics Successfully Completes First 1,6000L ... - Nasdaq
DUNDALK, Ireland, Jan. 31, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), …
WuXi Biologics Achieves Major Milestones at Ireland Site with …
Dundalk, Ireland, December 6, 2024 – WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today …